| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rigel Pharmaceuticals Inc (RIGL) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. RIGL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 31.7K | $851.5K | - | |
| CFO | 14.3K | $383.1K | - | |
| ? | 12.7K | $341.7K | - | |
| ? | 12.5K | $335.8K | - | |
| ? | 10.6K | $285.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2025 | Schorno Dean L | EVP &Chief Financial Officer | Sell | 3,770 | $21.38 | $80,614.84 | -3.1% | -20.1% | +45.4% | |
| Feb 5, 2025 | Santos David A | EVP, Chief Commercial Officer | Sell | 3,921 | $21.38 | $83,836.22 | -3.6% | -20.1% | +45.4% | |
| Feb 5, 2025 | Rodriguez Raul R60 | CEO, President | Sell | 9,352 | $21.39 | $200,075.19 | -1.9% | -20.1% | +45.4% | |
| Feb 5, 2025 | Furey Raymond J. | EVP, GC, CCO &Corp Sec | Sell | 2,787 | $21.40 | $59,652.52 | -3.4% | -20.1% | +45.4% | |
| Feb 5, 2024 | Santos David A | EVP, Chief Commercial Officer | Sell | 14,519 | $1.14 | $16,495.65 | -2.0% | +4.3% | +78.3% | |
| Feb 5, 2024 | Schorno Dean L | EVP &Chief Financial Officer | Sell | 12,628 | $1.14 | $14,337.67 | -1.5% | +4.3% | +78.3% | |
| Feb 5, 2024 | Rodriguez Raul R60 | CEO, President | Sell | 52,894 | $1.14 | $60,082.37 | -1.3% | +4.3% | +78.3% | |
| Feb 6, 2023 | Rodriguez Raul R60 | CEO, President | Sell | 20,340 | $1.75 | $35,595.00 | -1.2% | -30.4% | -28.7% | |
| Feb 2, 2023 | Santos David A | EVP, Chief Commercial Officer | Sell | 5,388 | $1.66 | $8,945.16 | -3.6% | -35.0% | -35.6% | |
| Feb 2, 2023 | Schorno Dean L | EVP &Chief Financial Officer | Sell | 5,389 | $1.66 | $8,946.28 | -2.7% | -35.0% | -35.6% |